Financial Performance - The company's operating revenue for Q3 2021 was ¥14,900,187.44, a decrease of 29.07% compared to the same period last year[4] - The net profit attributable to shareholders was -¥19,703,281.22, representing a decline of 326.14% year-on-year[4] - The net profit attributable to shareholders after deducting non-recurring gains and losses was -¥18,950,028.60, down 98.86% from the previous year[4] - The basic earnings per share for Q3 2021 was -¥0.13, a decrease of 347.27% year-on-year[4] - The weighted average return on net assets was -2.17%, down 1.58% from the previous year[4] - The net profit for the third quarter of 2021 was -48,240,537.98 CNY, compared to -21,629,548.14 CNY in the same period last year, indicating a significant increase in losses[23] - The net profit attributable to the parent company was -45,334,596.42 CNY, up from -20,800,994.38 CNY year-over-year[23] - Basic and diluted earnings per share were both -0.31 CNY, compared to -0.14 CNY in the same quarter last year[23] - The company reported a total comprehensive loss of -48,240,537.98 CNY for the quarter, compared to -25,199,002.10 CNY in the previous year[23] Cash Flow and Assets - The net cash flow from operating activities for the year-to-date was ¥492,408,969.47, an increase of 581.40%[4] - Cash and cash equivalents increased significantly to 235,332,422.31 yuan from 66,554,513.96 yuan, indicating a growth of approximately 253%[18] - Operating cash flow for the period was 492,408,969.47 CNY, a substantial improvement from -102,287,098.00 CNY in the previous year[26] - Total cash inflow from financing activities was 1,231,400,122.51 CNY, compared to 869,000,000.00 CNY in the prior year[27] - The cash and cash equivalents at the end of the period amounted to 94,037,723.76 CNY, up from 8,803,896.96 CNY at the end of the previous year[27] Assets and Liabilities - Total assets at the end of the reporting period were ¥3,007,250,716.24, reflecting a growth of 14.81% compared to the end of the previous year[4] - Total assets as of September 30, 2021, amounted to 3,007,250,716.24 yuan, an increase from 2,619,251,905.01 yuan at the end of 2020[19] - Total liabilities as of September 30, 2021, were 2,034,596,099.08 yuan, compared to 1,577,356,749.87 yuan at the end of 2020[20] - The total equity attributable to shareholders was ¥898,758,672.52, a decrease of 4.80% compared to the previous year[6] - The company’s equity attributable to shareholders decreased to 898,758,672.52 yuan from 944,093,268.94 yuan, a decline of approximately 4.8%[20] Investments and Collaborations - The company signed a cooperation agreement with the Qingdao West Coast New Area to develop a health industry cluster, focusing on medical devices and health services[12] - The company extended the management service period for a construction project with Ma'anshan Rural Commercial Bank by six months, with a service fee of ¥3,300,000[13] - The company acquired 30.15% equity in Weiyu Medical for a cash payment of 60 million yuan and completed the capital increase of 60 million yuan[15] - As of October 14, 2021, the company holds 33.74% equity in Weiyu Medical and controls 76.65% of the voting rights[15] - The company has made a total investment of 60 million yuan in Weiyu Medical as per the capital increase agreement[16] Operational Performance - Operating revenue for the current period was 51,393,605.88 yuan, up from 44,002,489.38 yuan in the previous period, representing a growth of approximately 16.3%[22] - Total operating costs increased to 114,074,545.02 yuan from 76,585,751.18 yuan, reflecting a rise of approximately 49%[22] - The company reported a net loss of 58,157,608.50 yuan for the current period, compared to a loss of 22,267,502.54 yuan in the previous period[22] Other Information - The cash outflow from investing activities was -160,760,069.53 CNY, compared to 190,949,218.68 CNY in the same period last year[27] - The company did not report any significant new product developments or market expansions during this quarter[28] - The third quarter report was not audited, indicating that the figures may be subject to change upon final review[28]
荣丰控股(000668) - 2021 Q3 - 季度财报